Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 28, 2005; 11(12): 1862-1866
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1862
Genetic distinctions between autoimmune hepatitis in Italy and North America
Paolo Muratori, Albert J. Czaja, Luigi Muratori, Georgios Pappas, Silvana Maccariello, Fabio Cassani, Alessandro Granito, Rodolfo Ferrari, Vilma Mantovani, Marco Lenzi, Francesco B. Bianchi
Paolo Muratori, Luigi Muratori, Georgios Pappas, Silvana Maccariello, Fabio Cassani, Alessandro Granito, Rodolfo Ferrari, Marco Lenzi, Francesco B. Bianchi, Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna
Albert J. Czaja, Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Foundation, Rochester, MN, USA
Vilma Mantovani, Laboratorio Centralizzato Settore Genetica, University of Bologna
Author contributions: All authors contributed equally to the work.
Correspondence to: Paolo Muratori, M.D., Dipartimento di Medicina Interna, Cardioangiologia, Epatologia Policlinico S.Orsola-Malpighi, via Massarenti, 9, 40138 Bologna, Italy. paolomuratori@tin.it
Telephone: +39-51-6363631 Fax: +39-51-340877
Received: October 28, 2004
Revised: October 29, 2004
Accepted: November 23, 2004
Published online: March 28, 2005
Abstract

AIM: Our goals were to analyze the known genetic predispositions for autoimmune hepatitis (AIH) in AIH Italian population and to compare them with North American counterparts.

METHODS: Human leukocyte antigens (HLA) B8, C7, DR3, DR4, DR7, DR11, DR13, DQ2 and the B8-DR3-DQ2 phenotype were determined by microlymphocytotoxicity and polymerase chain reaction in 74 Italian patients (57 with type 1 and 17 with type 2 AIH) and 149 North American patients with type 1 AIH, and in adequate controls.

RESULTS: B8-DR3-DQ2 occurred more frequently in Italian patients with type 1 AIH than in Italian controls (30% vs 7%, P<0.0001), but less frequently than in North American counterparts (30% vs 48%, P = 0.02). DR4 occurred less frequently in Italian patients with type 1 AIH (23% vs 43%, P = 0.01) and in controls (16% vs 34%, P = 0.0003) than in North American counterparts. No differences were found in alleles’ frequency between type 1 and type 2 Italian AIH patients. DR11 had a frequency lower in type 1 Italian AIH patients than controls (17% vs 35%, P = 0.01).

CONCLUSION: HLA DR4 is not associated with AIH in Italy. The known HLA risk factors for AIH occur similarly in Italian patients with type 1 and type 2 AIH, and they are less frequent than in North American patients. B8-DR3-DQ2 is the predominant phenotype of type 1 AIH also in Italy, and HLA DR11 may be a regionally distinctive protective factor against type 1 AIH.

Keywords: Type 1 autoimmune hepatitis; Type 2 autoimmune hepatitis; Human leukocyte antigen